GGiantBullStocks

COMPASS Pathways Plc - American Depository Shares (CMPS)

NASDAQ · Healthcare

$11.67-5.51%

As of Jul 20, 2026

Price history

Key statistics

Market cap
$1.25B
P/E ratio
EPS
Volume
5,565,052
52-week high
52-week low
Open
$12.16
Day high
$12.39
Day low
$11.64

Financial highlights

Fiscal yearRevenueNet incomeEPS
2025-$287.86M-$3.08
2024-$155.12M-$2.30
2023-$118.46M-$2.32
2022-$91.51M-$2.16
2021-$71.74M-$1.79

About COMPASS Pathways Plc - American Depository Shares

COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.

CEO
Kabir Kumar Nath
Employees
166
Country
GB
IPO date
Sep 18, 2020

Similar stocks

Other Healthcare companies

Frequently asked questions

What is COMPASS Pathways Plc - American Depository Shares's stock price today?
CMPS is trading at $11.67 as of Jul 20, 2026.
What is COMPASS Pathways Plc - American Depository Shares's market cap?
COMPASS Pathways Plc - American Depository Shares (CMPS) has a market capitalization of $1.25B.
Does COMPASS Pathways Plc - American Depository Shares pay a dividend?
COMPASS Pathways Plc - American Depository Shares did not pay a dividend in its most recent reported fiscal year.
What sector is COMPASS Pathways Plc - American Depository Shares in?
COMPASS Pathways Plc - American Depository Shares operates in the Healthcare sector.